Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IDEXX Laboratories

Is IDEXX Laboratories Stock Underperforming the S&P 500?

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart

A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts

5 analysts have shared their evaluations of IDEXX Laboratories (NASDAQ:IDXX) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

IDEXX Laboratories' Q3 2024 Earnings: What to Expect

IDEXX Laboratories is scheduled to release its fiscal third-quarter earnings this month, and analysts project a single-digit profit growth.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart

3 High-Profitability Healthcare Stocks to Buy for Consistent Returns

The healthcare industry's growth is driven by expanding healthcare needs, fast-rising demand for care services, and the increasing demand for smart medical devices. Given this backdrop, investors could consider buying fundamentally strong healthcare stocks such as IDEXX Laboratories (IDXX), Veeva Systems (VEEV), and Chemed Corporation (CHE) given their solid profitability…

StockNews.com

IDEXX Laboratories Stock: Is IDXX Underperforming the Healthcare Sector?

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

IDEXX Laboratories Stock Sees RS Rating Move Higher On Earnings Beat

IDEXX Laboratories sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains?

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

StockNews.com

IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a market capitalization of $30.26 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

4 Analysts Have This to Say About IDEXX Laboratories

Over the past 3 months, 4 analysts have published their opinion on IDEXX Laboratories (NASDAQ:IDXX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $12,000 Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 6.71% on an annualized basis producing an average annual return of 13.47%. Currently, IDEXX Laboratories has a market capitalization of $28.24 billion.

Benzinga

Here's How Much $100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 6.05% on an annualized basis producing an average annual return of 16.93%. Currently, IDEXX Laboratories has a market capitalization of $31.37 billion.

StockNews.com

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX Laboratories (IDXX) should benefit. But the stocks of which of these two companies is a better buy now? Read on to learn our…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

Upgrades

Benzinga

Recap: IDEXX Laboratories Q1 Earnings

IDEXX Laboratories (NASDAQ:IDXX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Earnings Preview For IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that IDEXX Laboratories will report an earnings per share (EPS) of $2.26.

Benzinga

IDEXX Laboratories Earnings Conference Call Is Coming Up, Here's What You Need To Know

IDEXX Laboratories (NASDAQ:IDXX) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results.

StockNews.com

Better Buy for 2022: Elanco Animal Health vs. IDEXX Laboratories

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…

Benzinga

IDEXX Laboratories Stock Gains On Q4 Earnings Beat, Upbeat FY22 Outlook

IDEXX Laboratories Inc (NASDAQ: IDXX) reported

Benzinga

IDEXX Laboratories: Q4 Earnings Insights

IDEXX Laboratories (NASDAQ:IDXX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

People

Mangeet Kaur BounsMangeet

595 stories

Neha PanjwaniFrom

97 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Palantir Technologies

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.